Revvity, formerly PerkinElmer, has undergone a major transformation over the past decade. Following the 2023 divestiture of its applied, food, and enterprise services business, the firm rebranded as Revvity and now operates through two core segments, diagnostics and life sciences, with a strategic focus on enabling scientific breakthroughs and improving health outcomes.